Tyra Biosciences, Inc.
Financial highlights
| Metric | FY 12/31/25 | FY 12/31/24 | FY 12/31/23 | FY 12/31/22 | FY 12/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Operating income | -$132.8 | -$104.2 | -$79.9 | -$58.9 | -$26.3 |
| Net income | -$119.9 | -$86.5 | -$69.1 | -$55.3 | -$26.3 |
| Cash Flow Statement | |||||
| Free cash flow | -$95.3 | -$70.4 | -$50.9 | -$50.8 | -$24.4 |
Shares outstanding 59.7M · Free float 38.0%
Annual filing data through FY ended December 31, 2025; float as of October 6, 2026.